
Global Sciences Announces Expansion of Aethics Hydration Product Line
November 19, 2019
Global Sciences Reports Q3 2019 Results with Revenue of $1.79 million up over 1,000% from Q3 2018 Revenue of $144,000
December 5, 2019CBD Global Sciences, Inc. today announced that its common shares have been listed on the Frankfurt Stock Exchange under the symbol “GS3.” The Company’s common shares continue to be listed on the Canadian Securities Exchange under the symbol “CBDN.”
Brad Wyatt, CEO of the Company, commented, “we are excited to provide shareholders of CBD Global additional market access in order to increase the continuing liquidity of CBD Global stock. We are also excited to enter the European marketplace as an access point for European investors in the ongoing CBD Global success story.”